Navigation Links
Wockhardt honoured with 2012 DIANA Award for Best Overall Generic Manufacturer
Date:6/15/2012

PARSIPPANY, N.J., June 15, 2012 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt announced that its US subsidiary, Wockhardt USA LLC was honoured with the presentation of the 2012 DIANA Award by the Healthcare Distribution Management Association (HDMA) for the 'Best Overall Generic Product Manufacturer' with sales of up to USD 100 million in the healthcare distributor market at their prestigious annual Business & Leadership Conference in San Antonio, Texas.

(Photo: http://photos.prnewswire.com/prnh/20120615/NY25710LOGO )

The Distribution Industry Awards for Notable Achievements in Healthcare (DIANA) Award is presented by HDMA to companies that continually foster strong trading partner relationships with the Association's primary distributor members by creating exceptional business practices that advance trade relations and benefit the entire healthcare supply chain.

"This award from HDMA is particularly significant and encouraging to Wockhardt's efforts in building strong relationships with our distributors and partners," said Wockhardt's Founder Chairman & Group CEO, Dr. Habil Khorakiwala.  "We are indeed honoured and elated with this recognition from HDMA," he further added.

About Wockhardt:

Wockhardt is a high-technology intensive global pharmaceutical and biotechnology company with multi-disciplinary and innovative R&D programmes.  It has 3 research centres globally and manufacturing facilities across India, USA, UK and Ireland.

Wockhardt has a significant presence in USA, Europe and India, with 75% of its global revenues coming from international businesses. With a large pool of Patents and Intellectual Property knowhow, Wockhardt is home to 590 scientists, of whom 80 are doctorates.  In all, Wockhardt has 158 Patents granted worldwide.  In biotechnology research, it has built a compet
'/>"/>

SOURCE Wockhardt
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
2. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
3. QBC Diagnostics Awarded GSA Contract
4. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
5. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
8. Northwest Bio Awarded $5.5 Million German Government Grant
9. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
10. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
11. Nominations Open for San Francisco Business Times Health Care Heroes Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance for ... fatigue. The need to urgently address this issue ... Sentinel Event Alert #50 , "Medical device alarm safety in ... between January 2008 and June 2012, there were 98 alarm ... in death (82%) , 13 resulted in permanent loss ...
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)... 2013   Nektar Therapeutics (Nasdaq: NKTR ... liability (HAL) study for NKTR-181, a first-in-class, opioid ... brain.  This slow rate of entry is designed to reduce ... addiction to current opioid analgesics. 1 In the study ... to placebo in "drug liking" and "feeling high" scores and ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9
... Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ... developer, manufacturer and seller of medicine and drugs ... announced that it plans to sell or transfer ... in the Chahaer Industrial Park, Inner Mongolia. Lotus, ...
... Inc. (OTC Bulletin Board: BHRT ) announced ... it finalized the formation of a working group. The ... clinical trial, combining a left ventricle assist device (LVAD) ... Bioheart,s MyoCath needle tipped catheter delivery system.   Initial ...
Cached Medicine Technology:Lotus Pharmaceuticals Announces Update on Land in Inner Mongolia 2Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 2Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 3Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 4Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 5
(Date:6/19/2013)... Casual, no-strings sexual encounters are increasingly common on ... than others to "hook up"? A new study ... Behavioral and Preventive Medicine, published online by the ... are certain factors and behaviors associated with sexual ... "Given the potential for negative emotional and physical ...
(Date:6/19/2013)... block the body,s system for repairing damage to the ... unlikely as it may seem, those compounds are sparking ... driven by a mutation in BRCA, a gene that ... the mutation. The compounds, termed PARP inhibitors, are the ... of Chemical & Engineering News . C&EN is ...
(Date:6/19/2013)... at Moffitt Cancer Center and colleagues at Louisiana State ... cancers that require immediate therapy. It relies on understanding ... goal is to better predict a prostate cancer,s aggressiveness ... was published in the online journal PLOS ONE ... cancer accounts for 20 percent of all cancers and ...
(Date:6/19/2013)... 19, 2013 Alternatives, a revolutionary new ... to quit using drugs while allowing them to continue ... founders of Alternatives, believe that abstinence-only approaches force people ... treatment and that this approach hurts instead of helping. ... the United States need treatment for addiction but only ...
(Date:6/19/2013)... Many trying-to-conceive couples seek medical ... according to a recent study published ... results of this research confirm what Fairhaven Health ... – that trying-to-conceive women would benefit from tracking ... weight. Fairhaven Health is a leading provider of ...
Breaking Medicine News(10 mins):Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4
... choosing a partner, women believe the lower the man,s voice, ... a woman with a higher voice is more likely to ... the latest edition of the online journal Evolutionary Psychology ... pitch and perceived infidelity and offers insight into the evolution ...
... Osteoarthritis - the most influential European bone meeting ... ,Palacio de Congresos, from March 23-26, 2011:,Register before ... of lower registration fees. Listen to ... Learn about key topics in 12 Meet-the-Professor Sessions, Take ...
... The combined effects of chemotherapy and endocrine therapy ... cancer survivors. In a study scheduled for publication in ... Medicine and Rehabilitation , researchers from the Oregon Health ... breast cancer survivors whether they had fallen in the ...
... HealthDay Reporter , THURSDAY, March 3 (HealthDay News) -- More ... than men are engaging in same-sex encounters, according to a ... In statistics compiled from interviews with 13,500 men and women ... Growth also indicates that more than half of young people ...
... (HealthDay News) -- Bunions, a common but painful deformity of the ... a new study has found. And the more severe the ... other parts of the body, leading to declines in both general ... is a bump that develops on the side of the big ...
... March 3, 2011 Unexpected results from a Scripps ... ideas about Alzheimer,s diseasepointing to the liver instead of the ... as brain plaques associated with this devastating condition. The findings ... treatment. The study was published online today in ...
Cached Medicine News:Health News:Can you predict your mate will cheat by their voice? 2Health News:Breast cancer survivors at higher risk for falls 2Health News:More Young People Delay Sex, Try Oral Sex First, CDC Says 2Health News:More Young People Delay Sex, Try Oral Sex First, CDC Says 3Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 2Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 3Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 4
PremierEdge Stab Knives - 30....
... for the total eye. Whether used ... mode or set independently to accommodate ... settings are adjustable to accommodate maximizing ... for use with tonometer-mounted, hand-held and ...
PremierEdge™ MVR Knives. Angled....
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
Medicine Products: